Cue Biopharma
36 hedge funds and large institutions have $15.2M invested in Cue Biopharma in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
53% less capital invested
Capital invested by funds: $32.4M → $15.2M (-$17.2M)
Holders
36
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$141K | |
| 2 | +$117K | |
| 3 | +$91K | |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$87K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$82.8K |
Top Sellers
| 1 | -$1.73M | |
| 2 | -$724K | |
| 3 | -$148K | |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
-$80.3K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$79K |